[Disease modifying antirheumatic drugs]. / Traitement de fond de la polyarthrite rhumatoïde.
Rev Med Suisse
; 10(421): 595-6, 598, 600-2, 2014 Mar 12.
Article
en Fr
| MEDLINE
| ID: mdl-24701712
ABSTRACT
The natural history of rheumatoid arthritis, previously burdened with high morbidity, has been strongly modified by appropriate treatment. Early diagnosis and treatment, and follow-up by a specialist, with the aim to achieve remission or low disease activity, are essential for the functional outcome of patients. Disease-modifying anti-rheumatic drugs include "conventional" treatments like methotrexate, biologic therapies such as TNF-inhibitors, abatacept, tocilizumab and rituximab, and targeted synthetic therapies such as tofacitinib (a JAK kinase inhibitor). New treatments currently under study should allow rheumatologists to successfully treat even more patients than nowadays.
Buscar en Google
Bases de datos:
MEDLINE
Asunto principal:
Artritis Reumatoide
/
Antirreumáticos
Tipo de estudio:
Screening_studies
Límite:
Humans
Idioma:
Fr
Revista:
Rev Med Suisse
Asunto de la revista:
MEDICINA
Año:
2014
Tipo del documento:
Article